U.S. Senators Express Concerns Over Experimental Zika Vaccine License, Accessibility, Pricing
STAT: More lawmakers want the Army to hold a hearing on Zika vaccine pricing
“A half dozen U.S. senators want the U.S. Army to hold a public hearing to explore the controversy over the pricing of a Zika virus vaccine that Sanofi is developing with taxpayer dollars. In a letter sent on Monday to Acting U.S. Secretary of the Army Robert Speer, the lawmakers expressed concerns that a vaccine would not be ‘accessible and affordable’ for many Americans, since the company may win an exclusive license to develop the technology and have ‘monopolistic’ rights through 2036…” (Silverman, 6/26).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.